Evidence map›Paper›PMID 26169051›Full record

ArticleHypertension (Dallas, Tex. : 1979)2015

Critical Role of Striatin in Blood Pressure and Vascular Responses to Dietary Sodium Intake.

Amanda E Garza, Luminita H Pojoga, Burhanuddin Moize, Wan M Hafiz, Lauren A Opsasnick, Waleed T Siddiqui, Michael Horenstein, Gail K Adler, Gordon H Williams, Raouf A Khalil

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03683069 (Hypertension and Striatin Gene Structure Related to Aldo Phenotype), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03683069 phase4completednot on this mapstarted 2019, after this paper: background citation

Hypertension and Striatin Gene Structure Related to Aldo Phenotype

TypeinterventionalSponsorBrigham and Women's HospitalRan2019 to 2024Enrolled90ConditionsHypertension, Genetics HypertensionArmsEplerenone vs Amlodipine
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Targeting PP2A in cancer: an underrated option.Journal of experimental & clinical cancer research : CR · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. The Effect of Aldosterone on Cardiorenal and Metabolic Systems.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amanda E GarzaFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Luminita H PojogaFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Burhanuddin MoizeFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Wan M HafizFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Lauren A OpsasnickFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Waleed T SiddiquiFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Michael HorensteinFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Gail K AdlerFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Gordon H WilliamsFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Raouf A KhalilFrom the Cardiovascular Endocrine Section, Division of Endocrinology, Diabetes and Hypertension (A.E.G., L.H.P., B.M., W.M.H., G.K.A., G.H.W.), and Division of Vascular Surgery (L.A.O., W.T.S., M.H., R.A.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. raouf_khalil@hms.harvard.edu.
Brigham and Women's Hospital · US

Funding

TRAINING PROGRAM IN HYPERTENSIONT32HL007609 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 1985 to 2022
$10.2M
Vascular Mechanisms in Pregnancy-Induced HypertensionR01HL065998 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KHALIL, RAOUF A · 2002 to 2016
$4.3M
Striatin, Aldosterone and HypertensionR01HL114765 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARZA, AMANDA ELIZABETH, WILLIAMS, GORDON H · 2013 to 2017
$4.3M
Salt Sensitive Hypertension and StriatinR01HL144779 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 2019 to 2022
$3.3M
Caveolin-1 and vascular dysfunctionR01HL104032 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI POJOGA, LUMINITA · 2010 to 2014
$2.1M
Mechanisms of Aldosterone Induced Cardiovascular DamageR01HL069208 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 2003 to 2006
$1.8M
Role of Endothelin B Receptor in Vascular Protection in FemalesR21HL098724 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHALIL, RAOUF A · 2010 to 2011
$481k
Mechano-Sensitive Hypoxia-Inducible Factor-MMP Pathway in Venous InsufficiencyR21HL111775 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHALIL, RAOUF A · 2013 to 2014
$475k
NHLBI NIH HHS HL-104032NHLBI NIH HHS HL-111775NHLBI NIH HHS HL-65998NHLBI NIH HHS HL-69208NHLBI NIH HHS HL-98724NHLBI NIH HHS R01 HL065998NHLBI NIH HHS R01 HL069208NHLBI NIH HHS R01 HL104032NHLBI NIH HHS R01 HL114765NHLBI NIH HHS R01 HL144779NHLBI NIH HHS R21 HL098724NHLBI NIH HHS R21 HL111775NHLBI NIH HHS T32 HL007609NHLBI NIH HHS T32HL007609
6 · The paper itself

Abstract

Striatin is a protein regulator of vesicular trafficking in neurons that also binds caveolin-1 and Ca(2+)-calmodulin and could activate endothelial nitric oxide synthase. We have shown that striatin colocalizes with the mineralocorticoid receptor and that mineralocorticoid receptor activation increases striatin levels in vascular cells. To test whether striatin is a regulator of vascular function, wild-type and heterozygous striatin-deficient mice (Strn(+/-)) were randomized in crossover intervention to restricted (0.03%) and liberal sodium (1.6%) diets for 7 days on each diet, and blood pressure and aortic vascular function were measured. Compared with wild-type, sodium restriction significantly reduced blood pressure in Strn(+/-). On liberal salt intake, phenylephrine and high KCl caused a greater vascular contraction in Strn(+/-) than wild-type, and endothelium removal, nitric oxide synthase inhibitor L-NAME, and guanylate cyclase inhibitor ODQ enhanced phenylephrine contraction to a smaller extent in Strn(+/-) than wild-type. On liberal salt, acetylcholine relaxation was less in Strn(+/-) than in wild-type, and endothelium removal, L-NAME, and ODQ blocked acetylcholine relaxation, suggesting changes in endothelial NO-cGMP. On liberal salt, endothelial nitric oxide synthase mRNA expression and the ratio of endothelial nitric oxide synthase activator pAkt/total Akt were decreased in Strn(+/-) versus wild-type. Vascular relaxation to NO donor sodium nitroprusside was not different among groups. Thus, striatin deficiency is associated with salt sensitivity of blood pressure, enhanced vasoconstriction, and decreased vascular relaxation, suggesting a critical role for striatin, through modulation of endothelial NO-cGMP, in regulation of vascular function and BP during changes in sodium intake.

Indexed as

AnimalsAortaBlood PressureCalmodulin-Binding ProteinsCyclic GMPEnzyme InhibitorsMaleMembrane ProteinsMiceMice, KnockoutNerve Tissue ProteinsNG-Nitroarginine Methyl EsterPhenylephrineProto-Oncogene Proteins c-aktSodium, DietaryVasoconstrictionCalmodulin-Binding ProteinsCyclic GMPEnzyme InhibitorsMembrane ProteinsNerve Tissue ProteinsNG-Nitroarginine Methyl EsterPhenylephrineProto-Oncogene Proteins c-aktSodium, DietaryStrn protein, mouseVasoconstrictor Agentsblood pressurecontractionendotheliumnitric oxidesmooth musclestriatin

Identifiers

PMID26169051
PMCPMC4537321
OpenAlexW2108420936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.